• About Us
  • Contact Us
  • Cookie policy (EU)
  • Home
  • Privacy Policy
  • Video
  • Write for us
Today Headline
  • HOME
  • NEWS
    • POLITICS
    • News for today
    • Borisov news
  • FINANCE
    • Business
    • Insurance
  • Video
  • TECHNOLOGY
  • ENTERPRISE
  • LIFESTYLE
    • TRAVEL
    • HEALTH
    • ENTERTAINMENT
  • AUTOMOTIVE
  • SPORTS
  • Travel and Tourism
  • HOME
  • NEWS
    • POLITICS
    • News for today
    • Borisov news
  • FINANCE
    • Business
    • Insurance
  • Video
  • TECHNOLOGY
  • ENTERPRISE
  • LIFESTYLE
    • TRAVEL
    • HEALTH
    • ENTERTAINMENT
  • AUTOMOTIVE
  • SPORTS
  • Travel and Tourism
No Result
View All Result
TodayHeadline
No Result
View All Result

Axicabtagene ciloleucel approved for second-line treatment of large B-cell lymphoma

April 16, 2022
in Health
0
Axicabtagene ciloleucel approved for second-line treatment of large B-cell lymphoma
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter


Axicabtagene ciloleucel approved for second-line treatment of LBCL

Axicabtagene ciloleucel (axi-cel; Yescarta) was approved for treatment of large B-cell lymphoma (LBCL) that is refractory to first-line chemoimmunotherapy or relapses within a year of first-line chemotherapy, the U.S. Food and Drug Administration announced April 1.

The approval of this chimeric antigen receptor (CAR) T-cell therapy offers an alternative to the standard of care for LBCL, a multistep process that starts with chemoimmunotherapy and then involves high-dose chemotherapy and a stem cell transplant for patients who respond to and can tolerate further treatment. CAR T-cell therapies are made from a patient’s white blood cells (T cells), which are removed and sent to a specialized manufacturing facility to be engineered to treat the patient’s cancer and are then infused back into the patient. Physicians and patients can begin accessing Yescarta T-cell therapy through authorized treatment centers in the United States.

The FDA based its approval on data from ZUMA-7, a randomized, open-label, multicenter trial of 359 patients with primary refractory LBCL or relapse within one year after completion of first-line therapy. Researchers randomly assigned patients to a single infusion of axi-cel following fludarabine and cyclophosphamide lymphodepleting chemotherapy or to second-line chemotherapy consisting of two or three cycles of chemoimmunotherapy followed by high-dose therapy and autologous hematopoietic stem cell transplantation in patients who attained complete or partial remission.

Patients in the axi-cel arm achieved significantly longer event-free survival (hazard ratio, 0.40), with an estimated 18-month event-free survival rate of 41.5 percent compared with 17.0 percent in the standard therapy arm. Estimated median event-free survival was 8.3 and 2.0 months in the axi-cel and standard therapy arms, respectively.

The prescribing information for axi-cel includes a boxed warning for cytokine release syndrome and neurologic toxicities. The most commonly reported adverse reactions have included cytokine release syndrome, fever, hypotension, encephalopathy, fatigue, tachycardia, headache, nausea, febrile neutropenia, diarrhea, musculoskeletal pain, infections, chills, and decreased appetite.

Approval was granted to Kite Pharma Inc.


Axi-cel proves effective as first-line treatment for high-risk lymphoma


More information:
FDA Approval

© 2022 HealthDay. All rights reserved.

Citation:
Axicabtagene ciloleucel approved for second-line treatment of large B-cell lymphoma (2022, April 15)
retrieved 15 April 2022
from https://medicalxpress.com/news/2022-04-axicabtagene-ciloleucel-second-line-treatment-large.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Tags: approvedAxicabtageneBcellciloleucellargelymphomasecondlinetreatment
Previous Post

Louis Pisano: Fashion writer apologises for spreading ‘reckless’ Rihanna and ASAP Rocky rumour

Next Post

Young Instagram users in UK face surge in impersonation scams

Related Posts

Robot-assisted surgery can cut blood clot risk and speed recovery, study finds – The Guardian
Health

Robot-assisted surgery can cut blood clot risk and speed recovery, study finds – The Guardian

https://amp.theguardian.com/society/2022/may/15/robot-assisted-surgery-can-cut-blood-clot-risk-and-speed-recovery-study-finds

Read more
Getting Less Than 6 Hours of Sleep Raises Dementia Risk — Best Life – Best Life
Health

Getting Less Than 6 Hours of Sleep Raises Dementia Risk — Best Life – Best Life

http://bestlifeonline.com/poor-sleep-dementia-risk-news/

Read more
Colorado has identified five cases of a mystery hepatitis in children – The Colorado Sun
Health

Colorado has identified five cases of a mystery hepatitis in children – The Colorado Sun

https://coloradosun.com/2022/05/16/colorado-hepatitis-children-unknown-cause/

Read more
Tragedy as boy, 3, labelled ‘attention seeking’ found to have aggressive brain tumour – Express
Health

Tragedy as boy, 3, labelled ‘attention seeking’ found to have aggressive brain tumour – Express

https://www.express.co.uk/news/uk/1610784/cancer-news-brain-tumour-medulloblastoma-attention-seeking-diagnosis-toddler

Read more
New information about mysterious hepatitis cases – KELOLAND.com
Health

New information about mysterious hepatitis cases – KELOLAND.com

https://www.keloland.com/news/healthbeat/new-information-about-mysterious-hepatitis-cases/

Read more
Load More
Next Post
Young Instagram users in UK face surge in impersonation scams

Young Instagram users in UK face surge in impersonation scams

  • Trending
  • Comments
  • Latest
6 Injured After Small Plane Crash Lands on Miami Bridge, Hitting SUV and Catching Fire – NBC 6 South Florida

6 Injured After Small Plane Crash Lands on Miami Bridge, Hitting SUV and Catching Fire – NBC 6 South Florida

Six times actors really romped in sex scenes that make 365 DNI look tame

Six times actors really romped in sex scenes that make 365 DNI look tame

Horror as goat gives birth to ‘humanoid kid’ with baby-like face

STUFFED GREEN PEPPERS – The Southern Lady Cooks

STUFFED GREEN PEPPERS – The Southern Lady Cooks

Robot-assisted surgery can cut blood clot risk and speed recovery, study finds – The Guardian

Robot-assisted surgery can cut blood clot risk and speed recovery, study finds – The Guardian

Getting Less Than 6 Hours of Sleep Raises Dementia Risk — Best Life – Best Life

Getting Less Than 6 Hours of Sleep Raises Dementia Risk — Best Life – Best Life

Colorado has identified five cases of a mystery hepatitis in children – The Colorado Sun

Colorado has identified five cases of a mystery hepatitis in children – The Colorado Sun

Europe’s growth forecast cut as energy crisis drives up inflation – business live | Business

About Us

Todayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.

Follow Us

Latest News

Robot-assisted surgery can cut blood clot risk and speed recovery, study finds – The Guardian

Robot-assisted surgery can cut blood clot risk and speed recovery, study finds – The Guardian

Getting Less Than 6 Hours of Sleep Raises Dementia Risk — Best Life – Best Life

Getting Less Than 6 Hours of Sleep Raises Dementia Risk — Best Life – Best Life

Robot-assisted surgery can cut blood clot risk and speed recovery, study finds – The Guardian

Robot-assisted surgery can cut blood clot risk and speed recovery, study finds – The Guardian

Getting Less Than 6 Hours of Sleep Raises Dementia Risk — Best Life – Best Life

Getting Less Than 6 Hours of Sleep Raises Dementia Risk — Best Life – Best Life

Colorado has identified five cases of a mystery hepatitis in children – The Colorado Sun

Colorado has identified five cases of a mystery hepatitis in children – The Colorado Sun

  • Real Estate
  • Education
  • Parenting
  • Cooking
  • Travel and Tourism
  • Home & Garden
  • Pets
  • Privacy & Policy
  • Contact
  • About

© 2021 All rights are reserved Todayheadline

No Result
View All Result
  • Real Estate
  • Education
  • Parenting
  • Cooking
  • Travel and Tourism
  • Home & Garden
  • Pets
  • Privacy & Policy
  • Contact
  • About

© 2021 All rights are reserved Todayheadline

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Posting....